Home1099 • HKG
add
Sinopharm Group Co Ltd
Nakaraang pagsara
$19.80
Sakop ng araw
$19.60 - $20.00
Sakop ng taon
$17.44 - $25.20
Market cap
61.98B HKD
Average na Volume
6.01M
P/E ratio
6.37
Dividend yield
4.81%
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 147.27B | 1.20% |
Gastos sa pagpapatakbo | 7.19B | 3.80% |
Net na kita | 1.42B | -10.70% |
Net profit margin | 0.96 | -11.93% |
Kita sa bawat share | — | — |
EBITDA | 3.91B | -13.51% |
Aktuwal na % ng binabayarang buwis | 23.21% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 48.91B | 3.62% |
Kabuuang asset | 413.07B | 2.78% |
Kabuuang sagutin | 290.20B | 0.49% |
Kabuuang equity | 122.86B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.81 | — |
Return on assets | 2.13% | — |
Return on capital | 4.25% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.42B | -10.70% |
Cash mula sa mga operasyon | -47.48B | -16.68% |
Cash mula sa pag-invest | 256.12M | -38.43% |
Cash mula sa financing | 22.15B | 4.94% |
Net change in cash | -25.07B | -30.76% |
Malayang cash flow | -24.53B | -79.75% |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
115,959
